IQVHealthcareiqvia.com
| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $3.96B | $3.83B | $4.02B | $4.10B | $4.36B | $4.15B | $4.37B | $4.43B | ▲ +8.0% |
| Gross profit | — | — | — | — | — | — | — | — | — |
| Operating income | $626.00M | $496.00M | $506.00M | $553.00M | $627.00M | $514.00M | $506.00M | $572.00M | ▲ +3.4% |
| Net income | $437.00M | $249.00M | $266.00M | $331.00M | $514.00M | $274.00M | $256.00M | $350.00M | ▲ +5.7% |
| R&D | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | — | 1.40 $ | 1.54 $ | 1.93 $ | — | 1.61 $ | 1.53 $ | 2.10 $ | ▲ +8.8% |
| Margins (% of revenue) | |||||||||
| Gross | — | — | — | — | — | — | — | — | — |
| Operating | 15.8 % | 13.0 % | 12.6 % | 13.5 % | 14.4 % | 12.4 % | 11.6 % | 12.9 % | ▼ -0.6 pt |
| Net | 11.0 % | 6.5 % | 6.6 % | 8.1 % | 11.8 % | 6.6 % | 5.9 % | 7.9 % | ▼ -0.2 pt |
| Balance sheet | |||||||||
| Assets | $26.90B | $27.32B | $28.63B | $28.73B | $29.94B | $29.68B | $29.88B | $30.47B | ▲ +6.1% |
| Liabilities | $20.83B | $21.34B | $22.85B | $22.44B | $23.31B | $23.33B | $23.58B | $23.68B | ▲ +5.5% |
| Equity | $6.07B | $5.99B | $5.79B | $6.29B | $6.63B | $6.35B | $6.30B | $6.79B | ▲ +8.0% |
| Cash | $1.70B | $1.74B | $2.04B | $1.81B | $1.98B | $1.95B | $1.91B | $2.25B | ▲ +24.0% |
| Capital | |||||||||
| Shares outstanding | 176.10M | 173.00M | 170.00M | 170.30M | 169.70M | 166.90M | 164.60M | 164.80M | ▼ -3.2% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.